FUGESP
Revista de Gastroenterologia da Fugesp - ESOMEPRAZOL
Jul/Ago-2001

BIBLIOGRAFIA

  • BOCKUS - Gastroenterology 1995
  • COTTON PB, TYTGAT GNJ and WILLIAMS CB. Annual of Gastrointestinal Endocopy 1996 9th Edition Rapid Science Publishers 1996
  • DENT J et al. - An evidence- based appraisal of disease management: the Genval workshop report. GUT1999;44(suppl): S1- 16
  • KAHRILAS PJ et al. - Esomeprazole impruves healing and symptom resolution as compared with omeprazole in refluxo esophagitis patients: a randomized controlled trial. Aliment. Pharmacol. Ther. 2000; 14: 1249-58
  • KAHILAS PJ, QUIGLEY EM, CASTELL DO, SPECHLER SJ.- The effects of tegaserod (HTF919) on oesophageal acid exposure in gastro-oesophageal reflux diseas. Aliment Pharmacol Ther 2000 nov;14 (11): 1503-9
  • LAUDANNA A A - Halitose in Laudanna. Gastroenterologia Clínica. Ed. Santos 1990
  • PANTOFLICKOVA D, BLUM AL, KOELZ HR: Helicobacter pylori and funcional dyspepsia: a real causal link? Baillieres Clin Gastroenterol 1998,12: 503-532
  • SAKAI P, ISHIOKA S, MALUF FILHO F. Tratado de Endoscopia Digestiva Diagnóstica e Terapêutica vol.II Ed. Atheneu São Paulo 2001
  • RICHTER JE et al. -Esomeprazole is superior to omeprazole for the healing of erosive esophagitis (EE) in GERD patients. Gastroenterology 2000; 118(4): A20. Abs.343.
  • SLEINSINGER - FORDTRAN. Gastrointestinal Disease 1990
  • TALLEY NJ et al. - Esomeprazole 40mg and 20 mg is efficacious in the long-term manegement of patients with endoscopy- negative GERD: a placebo- controlled trial of on-demand therapy for 6 months. Gastroenterology 2000;118 (4) :A658.
 

www.fugesp.org.br
FUGESP - Fundação Médico-Cultural de Gastroenterologia e Nutrição de São Paulo
Rua Itacolomi, 601 - 4º andar - Conjunto 46 - Higienópolis - Cep: 01239-020 - São Paulo - SP
© Copyright 2005, FUGESP